Esophageal carcinoma (squamous + adeno) · None

Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.

Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.

Source YAML: complete record

Track	standard
Linked regimen	`None`

ID	`IND-ACHALASIA-ESOPHAGEAL-PREVENTION-SURVEILLANCE`
Type	Indication
Status	reviewed 2026-05-18 \| pending_clinical_signoff
Diseases	`DIS-ESOPHAGEAL`
Sources	`SRC-NCCN-BCELL-2025` `SRC-NCCN-ESOPHAGEAL-2025`

Notes

STUB — v0.3 chronic-condition prevention pilot (achalasia). Two-Co- Lead signoff queued. Surveillance benefit rests on cohort evidence (no RCTs feasible given low absolute incidence). Lugol's chromo- endoscopy availability is the major equity constraint.

Used By

Indication

IND-ACHALASIA-ESOPHAGEAL-PREVENTION-OBSERVATION - IND-ACHALASIA-ESOPHAGEAL-PREVENTION-OBSERVATION

Red flag

RF-ACHALASIA-ESOPHAGEAL-PREVENTION - Achalasia (primary esophageal motor disorder with impaired LES relaxation and loss of eso...